FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765762403> ?p ?o ?g. }

• W2765762403 endingPage "904" @default.
• W2765762403 startingPage "893" @default.
• W2765762403 abstract "A home-based, low-intensity physical activity program (Onco-Move) and a supervised, moderate-to-high intensity, combined resistance and aerobic exercise program (OnTrack) have proven to be effective in maintaining physical fitness and reducing fatigue among breast cancer patients undergoing adjuvant chemotherapy. This study evaluated the cost–utility and cost-effectiveness of Onco-Move and OnTrack. A total of 230 patients were randomized to Onco-Move, OnTrack, or usual care (UC). Health outcomes included quality-adjusted life years (QALYs), general and physical fatigue, and physical fitness measured at baseline, end of chemotherapy, and 6-month follow-up. Societal costs included professional and informal health care, work absenteeism, and unpaid productivity costs. Cost data were based on 3-monthly questionnaires, supplemented by medication data obtained from pharmacies. Onco-Move is not likely to be cost-effective due to the relatively high willingness-to-pay necessary to reach reasonable probabilities of cost-effectiveness (QALY, general and physical fatigue). Incremental cost-effectiveness ratios for OnTrack compared to UC were €26,916/QALY, €788/1-point decrease in general fatigue and €1402/1-point decrease in physical fatigue. The probability of OnTrack being cost-effective ranged from 31% at a willingness-to-pay (WTP) of €0–79% at a WTP of €80,000/QALY, 97% at a WTP of €15,000/1-point decrease in general fatigue, and 86% at a WTP of €24,000/1-point decrease in physical fatigue. Both interventions had a low probability of being cost-effective for physical fitness. The probability of cost-effectiveness for both interventions was greater among compliant participants. Onco-Move is not likely to be cost-effective. Depending on the decision-makers’ willingness-to-pay, OnTrack could be considered cost-effective in comparison with UC. Trial registration Clinical trial registration number of the Netherlands Trial Register—NTR2159." @default.
• W2765762403 created "2017-11-10" @default.
• W2765762403 creator A5005916544 @default.
• W2765762403 creator A5008949837 @default.
• W2765762403 creator A5014778448 @default.
• W2765762403 creator A5017168489 @default.
• W2765762403 creator A5032574824 @default.
• W2765762403 creator A5072317673 @default.
• W2765762403 creator A5082015784 @default.
• W2765762403 creator A5087782965 @default.
• W2765762403 date "2017-10-30" @default.
• W2765762403 modified "2023-10-03" @default.
• W2765762403 title "Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy" @default.
• W2765762403 cites W1590770963 @default.
• W2765762403 cites W1701849548 @default.
• W2765762403 cites W1969606544 @default.
• W2765762403 cites W1984576858 @default.
• W2765762403 cites W1997549469 @default.
• W2765762403 cites W2003239266 @default.
• W2765762403 cites W2023909968 @default.
• W2765762403 cites W2045291273 @default.
• W2765762403 cites W2047628505 @default.
• W2765762403 cites W2050081960 @default.
• W2765762403 cites W2055936215 @default.
• W2765762403 cites W2061713380 @default.
• W2765762403 cites W2065974896 @default.
• W2765762403 cites W2066028007 @default.
• W2765762403 cites W2068557550 @default.
• W2765762403 cites W2069086045 @default.
• W2765762403 cites W2074479676 @default.
• W2765762403 cites W2096391232 @default.
• W2765762403 cites W2102553735 @default.
• W2765762403 cites W2114813555 @default.
• W2765762403 cites W2118502261 @default.
• W2765762403 cites W2130857683 @default.
• W2765762403 cites W2134843796 @default.
• W2765762403 cites W2150106013 @default.
• W2765762403 cites W2156420703 @default.
• W2765762403 cites W4229709431 @default.
• W2765762403 doi "https://doi.org/10.1007/s10198-017-0936-0" @default.
• W2765762403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29086085" @default.
• W2765762403 hasPublicationYear "2017" @default.
• W2765762403 type Work @default.
• W2765762403 sameAs 2765762403 @default.
• W2765762403 citedByCount "36" @default.
• W2765762403 countsByYear W27657624032017 @default.
• W2765762403 countsByYear W27657624032018 @default.
• W2765762403 countsByYear W27657624032019 @default.
• W2765762403 countsByYear W27657624032020 @default.
• W2765762403 countsByYear W27657624032021 @default.
• W2765762403 countsByYear W27657624032022 @default.
• W2765762403 countsByYear W27657624032023 @default.
• W2765762403 crossrefType "journal-article" @default.
• W2765762403 hasAuthorship W2765762403A5005916544 @default.
• W2765762403 hasAuthorship W2765762403A5008949837 @default.
• W2765762403 hasAuthorship W2765762403A5014778448 @default.
• W2765762403 hasAuthorship W2765762403A5017168489 @default.
• W2765762403 hasAuthorship W2765762403A5032574824 @default.
• W2765762403 hasAuthorship W2765762403A5072317673 @default.
• W2765762403 hasAuthorship W2765762403A5082015784 @default.
• W2765762403 hasAuthorship W2765762403A5087782965 @default.
• W2765762403 hasBestOaLocation W27657624032 @default.
• W2765762403 hasConcept C112930515 @default.
• W2765762403 hasConcept C138816342 @default.
• W2765762403 hasConcept C15744967 @default.
• W2765762403 hasConcept C159110408 @default.
• W2765762403 hasConcept C162324750 @default.
• W2765762403 hasConcept C171687745 @default.
• W2765762403 hasConcept C175444787 @default.
• W2765762403 hasConcept C1862650 @default.
• W2765762403 hasConcept C27400517 @default.
• W2765762403 hasConcept C2777364431 @default.
• W2765762403 hasConcept C2779951463 @default.
• W2765762403 hasConcept C3019080777 @default.
• W2765762403 hasConcept C524218345 @default.
• W2765762403 hasConcept C64332521 @default.
• W2765762403 hasConcept C71924100 @default.
• W2765762403 hasConcept C77805123 @default.
• W2765762403 hasConceptScore W2765762403C112930515 @default.
• W2765762403 hasConceptScore W2765762403C138816342 @default.
• W2765762403 hasConceptScore W2765762403C15744967 @default.
• W2765762403 hasConceptScore W2765762403C159110408 @default.
• W2765762403 hasConceptScore W2765762403C162324750 @default.
• W2765762403 hasConceptScore W2765762403C171687745 @default.
• W2765762403 hasConceptScore W2765762403C175444787 @default.
• W2765762403 hasConceptScore W2765762403C1862650 @default.
• W2765762403 hasConceptScore W2765762403C27400517 @default.
• W2765762403 hasConceptScore W2765762403C2777364431 @default.
• W2765762403 hasConceptScore W2765762403C2779951463 @default.
• W2765762403 hasConceptScore W2765762403C3019080777 @default.
• W2765762403 hasConceptScore W2765762403C524218345 @default.
• W2765762403 hasConceptScore W2765762403C64332521 @default.
• W2765762403 hasConceptScore W2765762403C71924100 @default.
• W2765762403 hasConceptScore W2765762403C77805123 @default.
• W2765762403 hasFunder F4320322777 @default.
• W2765762403 hasFunder F4320324343 @default.
• W2765762403 hasIssue "6" @default.
• W2765762403 hasLocation W27657624031 @default.

• next